Following a highly successful year and several drug discovery milestones using its flagship AI platform, Exscientia are pleased to welcome Andrew Douglas as the new Director of Data Engineering. Andrew

Frontier IP Chief Executive Officer Neil Crabb said: “We’re delighted to welcome Insignals to the Frontier IP family. The Company’s technology has the potential to improve the accuracy of where

This year, more than 560,000 people have applied to study at British universities, including in excess of 100,000 from overseas. Our higher education is particularly highly prized at postgraduate level

Neil Crabb, chief executive officer of Frontier IP, said: “We are delighted the SBRI is backing this programme, which validates our approach to IP commercialisation. Through Amprologix and Professor Upton’s ground-breaking

Frontier IP chief executive officer Neil Crabb said: “This grant from the UK’s leading charity dedicated to helping people who need to live without gluten and the involvement of three

Frontier IP chief executive officer Neil Crabb said: “TVG’s novel vaccine technology has the potential to play a material role in beating the threats of antimicrobial resistance and, more widely,

Following a recent story with the top twenty companies in the area of AI drug development, this time we will make a flight over this new ecosystem looking for the

MSPs debated the importance of life sciences to the Scottish economy on Wednesday to mark the second anniversary of the industry-led Life Sciences Strategy. North East Scotland Conservative MSP Bill

Frontier IP chief executive officer Neil Crabb said: “Today’s announcements confirm Exscientia’s exciting potential. The strong support for the financing round from major companies in the life sciences industry and

Former AIM writer of the year Andrew Hore names the AIM companies he believes have strong growth prospects over the next year and beyond. Frontier IP (FIPP) Frontier IP (LON:FIPP)